First Page | Meta Content | |
---|---|---|
Document Date: 2009-05-22 05:47:44Open Document File Size: 338,95 KBShare Result on FacebookCityKraków / /CountryPoland / /FacilityInstitute of Pharmacology / Institute of Pharmacology Polish Academy / /IndustryTermenergy minimum / signal transduction systems / treatment of CNS disorders / potential hydrogen bond-forming site / differentiated chemical structure / putative site / glycosylation site / low-energy conformations / cell systems / treatment of jet lag and sleep disorders / food intake / putative recognition site / treatment of cognitive disorders / treatment of epilepsy / chemical structure / Chemical structures / /MedicalConditionbehavioral syndrome / hypertension / schizophrenia / specific behavioral syndrome / vascular disorders / complex psychiatric disorders / peripheral vessels diseases / dysfunction / migraine / chronic exposure / cognitive disorders / CNS disorders / mental fatigue / neuropsychiatric and other diseases / affective disorder / epilepsy / dose-dependent behavioral syndrome / rat maximal electroshock seizure / neuropsychiatric disorders / memory deficits / sleep disorders / depression / /OrganizationNational Institute of Health / Pharmacology Polish Academy / 5-HT6 AND 5-HT7 SEROTONIN RECEPTORS Anna Weso³owska Department of New Drug Research / Serotonin Club Receptor Nomenclature Committee / National Park Service / Institute of Pharmacology / General Services Administration / Polish Academy of Sciences / /PersonAnna Weso³owska / /Positionsecond messenger / messenger / /Productfluoxetine / clozapine / haloperidol / carbamazepine / Risperidone / atropine / adenosine / /Technologymolecular modeling / tomography / hybridization / PKI / /SocialTag |